Publications by authors named "Meyer Heyman"

Claim this Profile
A
A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia.
Li Zhang, Sindhuja Marupudi, Tamil Kuppusamy, William LaRosa, Paul Turer, Meyer Heyman

Case Rep Nephrol Dial· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Bhuvaneswari Ramkumar, Manpreet K Chadha, Maurice Barcos, Sheila N J Sait, Meyer R Heyman

Cancer Genet Cytogenet· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Ashraf Badros, Olga Goloubeva, Jay S Dalal, Ilyas Can, Jennifer Thompson, Meyer Heyman

Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
Francis K Buadi, Meyer R Heyman, Christopher D Gocke, Aaron P Rapoport, Roger Hakimian

Am J Hematol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
April Deng, Christopher D Gocke, John Hess, Meyer Heyman, Michael Paltiel

Arch Dermatol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual leukemia presentations. Case 2. Granulocytic sarcoma of the colon.
Mohan Tummala, Leno Thomas, Christopher Gocke, Meyer R Heyman, Ivana Gojo

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients.
Ashraf Z Badros, Olga Goloubeva, Aaron P Rapoport, Bashi Ratterree, Natalie Gahres, Meyer Heyman

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
Naoko Takebe, Xiangfei Cheng, Suhlan Wu, Kenneth Bauer, Olga G Goloubeva, Meyer Heyman

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin.
David G Neschis, Meyer R Heyman, Vasana Cheanvechai, Marshall E Benjamin, William R Flinn

J Vasc Surg· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis